GENE ONLINE|News &
Opinion
Blog

Go Prime
These Two Companies are Helping Push Denmark to the Forefront of Biotech
2022-04-21
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
Compensating for OxyContin: The Harm from Pharma
2022-04-12
Insider: Groundbreaking Malaria Vaccine Reinvigorates the Fight against Disease
2022-03-30
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
From Forbidden Drugs to Psychotropic Cures: A “Psychedelic Boom” Breaks New Ground in Treating Mental Illnesses
2022-03-08
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
Sex Dimorphism in Obesity and the Impact of Estrogen Hormone Therapy on Cardiometabolic Health
2022-01-17
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021
2022-01-07
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Brukinsa Receives EU Approval for the Treatment of Rare Lymphoma
2021-11-27
Cancer Cells Build Nano-Highways to Hijack Mitochondria from Immune Cells
2021-11-25
1 2 3 4 11
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top